Fed Completed Phase 1 Trials for Risperidone (DB00734)

Also known as: FED

IndicationStatusPhase
DBCOND0052071 (Fed)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01618760Bioequivalence Study of Risperidone Tablet 1 mg Under Fed ConditionTreatment